Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Abramsky

Showing results (211-220 of 240) with videos related to

Pageof 24
Sort By:
The Journal of Clinical Investigation|December 1, 1988
In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genesS Brocke, C Brautbar, L Steinman, et al.
American Journal of Diseases of Children (1960)|March 1, 1981
Antiacetylcholine receptor antibody in neonatal myasthenia gravisJ O Donaldson, A S Penn, R P Lisak, et al.
Annals of Neurology|November 1, 1991
Hereditary branching enzyme dysfunction in adult polyglucosan body disease: a possible metabolic cause in two patientsA Lossos, V Barash, D Soffer, et al.
Neurology|September 1, 1981
Polyclonal B-cell activity in myasthenia gravisA I Levinson, A Dziarski, R P Lisak, et al.
Journal of Neuroimmunology|April 3, 2001
Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with CopaxoneT Brenner, R Arnon, M Sela, et al.
Transactions of the American Neurological Association|January 1, 1981
Human fetal alpha-fetoprotein fractions inhibit antibody-mediated lysis of oligodendrocytes in vitroI Lubetzki-Korn, D H Silberberg, M Hirayama, et al.
Neuroscience Letters|April 1, 1980
Antisera to bovine oligodendroglia raised in guinea pigs bind to surface of rat oligodendroglia and Schwann cellsR P Lisak, R M Pruss, P G Kennedy, et al.
Archives of Neurology|May 18, 1999
HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi JewsO J Kwon, A Karni, S Israel, et al.
Annals of Neurology|December 16, 1998
Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme geneA Lossos, Z Meiner, V Barash, et al.
Journal of Neuroimmunology|April 1, 1997
Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitisD Lehmann, D M Karussis, D Fluresco, et al.
Pageof 24

Showing results (211-220 of 240) with videos related to

Sort By:
Pageof 24
The Journal of Clinical Investigation|December 1, 1988
In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genesS Brocke, C Brautbar, L Steinman, et al.
American Journal of Diseases of Children (1960)|March 1, 1981
Antiacetylcholine receptor antibody in neonatal myasthenia gravisJ O Donaldson, A S Penn, R P Lisak, et al.
Annals of Neurology|November 1, 1991
Hereditary branching enzyme dysfunction in adult polyglucosan body disease: a possible metabolic cause in two patientsA Lossos, V Barash, D Soffer, et al.
Neurology|September 1, 1981
Polyclonal B-cell activity in myasthenia gravisA I Levinson, A Dziarski, R P Lisak, et al.
Journal of Neuroimmunology|April 3, 2001
Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with CopaxoneT Brenner, R Arnon, M Sela, et al.
Transactions of the American Neurological Association|January 1, 1981
Human fetal alpha-fetoprotein fractions inhibit antibody-mediated lysis of oligodendrocytes in vitroI Lubetzki-Korn, D H Silberberg, M Hirayama, et al.
Neuroscience Letters|April 1, 1980
Antisera to bovine oligodendroglia raised in guinea pigs bind to surface of rat oligodendroglia and Schwann cellsR P Lisak, R M Pruss, P G Kennedy, et al.
Archives of Neurology|May 18, 1999
HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi JewsO J Kwon, A Karni, S Israel, et al.
Annals of Neurology|December 16, 1998
Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme geneA Lossos, Z Meiner, V Barash, et al.
Journal of Neuroimmunology|April 1, 1997
Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitisD Lehmann, D M Karussis, D Fluresco, et al.
Pageof 24